Cargando…
Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer’s Disease
Serum metabolomics and lipidomics are powerful approaches for discovering unique biomarkers in various diseases and associated therapeutics and for revealing metabolic mechanisms of both. Treatment with Benfotiamine (BFT), a thiamine prodrug, for one year produced encouraging results for patients wi...
Autores principales: | Bhawal, Ruchika, Fu, Qin, Anderson, Elizabeth T., Gibson, Gary E., Zhang, Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709126/ https://www.ncbi.nlm.nih.gov/pubmed/34947984 http://dx.doi.org/10.3390/ijms222413188 |
Ejemplares similares
-
Identifying potential biomarkers and therapeutic targets for dogs with sepsis using metabolomics and lipidomics analyses
por: Montague, Brett, et al.
Publicado: (2022) -
Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles
por: Llano, Daniel A., et al.
Publicado: (2020) -
Thiamine and benfotiamine: Focus on their therapeutic potential
por: Bozic, Iva, et al.
Publicado: (2023) -
Serum metabolomic and lipidomic profiling identifies diagnostic biomarkers for seropositive and seronegative rheumatoid arthritis patients
por: Luan, Hemi, et al.
Publicado: (2021) -
Preventive effects of benfotiamine in chronic diabetic complications
por: Chakrabarti, Rana, et al.
Publicado: (2011)